OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 18.03.2026, 14:50

Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

Modernizing Clinical Data Management with Artificial Intelligence

2022·0 Zitationen·International Journal of Science and Research (IJSR)Open Access
Volltext beim Verlag öffnen

0

Zitationen

1

Autoren

2022

Jahr

Abstract

The recent decade has witnessed a threefold es- calation in the volume of clinical trial data, posing significant challenges for sponsors and CROs tasked with its management. With a substantial proportion of trial data now originating from external sources beyond traditional EDC systems, there is a pressing need for sophisticated data handling strategies. Additionally, data inflow velocity has outpaced conventional re- porting methods? capacity to facilitate prompt and informed trial decision-making. This paper contends that Artificial Intelligence (AI) is indispensable for modernizing clinical data management. AI?s adeptness in processing expansive datasets equips it to swiftly unearth anomalies, streamline patient recruitment, and enhance the fidelity of data analysis. By automating the labor- intensive aspects of data management, AI liberates research teams to concentrate on interpreting complex data, thereby bolstering the safety and efficacy evaluation of new therapeutics. Adopting AI in clinical data management is not an endeavor free from apprehension, particularly within an industry that prizes regulatory compliance and job security. Nevertheless, AI is posited not as a usurper of human roles but as a facilitator that enriches the acumen of clinical professionals. This advancement encourages a synergistic relationship between technology and expertise, fostering more efficient and robust clinical trials. In the milieu of escalating data demands, AI is an essential tool for clinical researchers, enabling them to navigate the complexities of modern trial data and expedite the journey of new drugs from conception to market.

Ähnliche Arbeiten

Autoren

Institutionen

Themen

Artificial Intelligence in Healthcare and EducationArtificial Intelligence in HealthcareMachine Learning in Healthcare
Volltext beim Verlag öffnen